Search all medical codes

Amphetamines; 5 or more

CPT4 code

Name of the Procedure:

Amphetamines; 5 or more

  • Common name: Amphetamine Test
  • Technical term: Amphetamine Urine Screen (5 or more amphetamines tested)

Summary

An amphetamine urine screen is a simple test used to detect the presence of amphetamines in the urine. This procedure is typically performed to check for substance use or abuse, often as part of a drug screening program.

Purpose

  • Medical condition or problem addressed: Substance abuse, particularly the use of amphetamines.
  • Goals or expected outcomes: To identify or rule out the use of amphetamines, helping in diagnostic or monitoring processes for various conditions, including substance abuse treatments or compliance with prescribed medications.

Indications

  • Specific symptoms or conditions: Suspicion of amphetamine abuse, participation in drug rehabilitation programs, pre-employment screening, legal or forensic investigations.
  • Patient criteria: Individuals with a history of substance abuse, those under monitored drug treatment, employees in certain high-responsibility jobs.

Preparation

  • Pre-procedure instructions: No special preparation is typically required. Patients should inform healthcare providers of all medications and supplements they are taking, as some substances might affect test results.
  • Diagnostic tests or assessments: None required beforehand.

Procedure Description

  1. Collection: The patient is asked to provide a urine sample in a clean container.
  2. Analysis: The urine sample is sent to a laboratory where it is tested for the presence of at least five types of amphetamines.
  3. Technology used: Immunoassay screening, followed by a confirmatory test such as gas chromatography-mass spectrometry (GC-MS) if initial results are positive.
  4. Anesthesia or sedation: Not applicable.

Duration

  • Typical time: The collection of the urine sample takes a few minutes, while laboratory analysis can take a few hours to a few days, depending on the specific facility and testing method used.

Setting

  • Location: Outpatient clinic, hospital, or specialized laboratory.

Personnel

  • Healthcare professionals involved: Nurses or medical technicians usually handle the sample collection, while laboratory technicians perform the analysis.

Risks and Complications

  • Common risks: Minimal to none, as it is a non-invasive test.
  • Rare risks: Contamination or improper handling of the sample can produce inaccurate results, but such issues are generally mitigated with standard protocols.

Benefits

  • Expected benefits: Accurate detection or exclusion of amphetamine use, aiding in medical diagnosis or compliance monitoring. Results typically available within a few days.

Recovery

  • Post-procedure care and instructions: None required.
  • Expected recovery time: Immediate, as the procedure does not impact physical health.
  • Restrictions or follow-up: No restrictions. Follow-up may be required if results are positive for further assessment or intervention.

Alternatives

  • Other treatment options: Blood test for amphetamines, hair follicle test.
  • Pros and cons: Blood tests can detect more recent use but are more invasive. Hair follicle tests can detect longer-term use but are more costly and have a longer turn-around time for results.

Patient Experience

  • During the procedure: Painless urine sample collection.
  • After the procedure: No discomfort expected. Potential anxiety while awaiting results, which can be managed with support from healthcare providers.
  • Pain management and comfort measures: Not applicable, as the procedure is non-invasive and pain-free.